Khaled Musallam/LinkedIn
May 9, 2026, 13:50
Khaled Musallam: Listening to Patients’ Needs and Challenges Remains the Foundation for a Better Care
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
”One of the most rewarding moments on International Thalassemia Day is sitting together with our patients, hearing firsthand how advances in care and the growth of our center have transformed their disease journey, daily lives, and outlook for the future.
At the same time, these conversations remind us that our work is far from over, and that listening to patients’ persisting needs and challenges remains the foundation for building better and more equitable care.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy